Discovery of Antischistosomal Drug Leads Based on Tetraazamacrocyclic Derivatives and Their Metal Complexes

Praziquantel (PZQ) is the only drug available for the treatment of schistosomiasis, and since its large-scale use might be associated with the onset of resistance, new antischistosomal drugs should be developed. A series of 26 synthetic tetraazamacrocyclic derivatives and their metal complexes were...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Khan, M. O. Faruk, Keiser, Jennifer, Amoyaw, P. N. A., Hossain, Mohammad F., Vargas, Mireille, Le, Justin G., Simpson, Natalie C., Roewe, Kimberly D., Freeman, TaRynn N. Carder, Hasley, Travis R., Maples, Randall D., Archibald, Stephen J., Hubin, Timothy J.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2016
Matèries:
Susceptibility
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4997856/
https://ncbi.nlm.nih.gov/pubmed/27324765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00778-16
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars